

Breaking Barriers in Science: The Women of DoubleRainbow Biosciences

Landkind announces GRAS status for biosynthesized salidroside

Landkind delivers cognitive function boost with GRAS-approved pure salidroside supplement

2022: The year of acceleration

Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside

Double Rainbow ramps up production of ancient natural painkiller

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

NutraCast: Utilizing synthetic biology to preserve medicinal plants

DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE

Big Pharma’s Green Ambitions
Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech
